- Home
- TRDA vs MCR Comparison
TRDA vs MCR Comparison
Compare TRDA & MCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRDA
- MCR
- Stock Information
- Founded
- TRDA 2016
- MCR 1989
- Country
- TRDA United States
- MCR United States
- Employees
- TRDA N/A
- MCR N/A
- Industry
- TRDA Biotechnology: Pharmaceutical Preparations
- MCR Trusts Except Educational Religious and Charitable
- Sector
- TRDA Health Care
- MCR Finance
- Exchange
- TRDA Nasdaq
- MCR Nasdaq
- Market Cap
- TRDA 301.0M
- MCR 250.1M
- IPO Year
- TRDA 2021
- MCR N/A
- Fundamental
- Price
- TRDA $7.12
- MCR $6.27
- Analyst Decision
- TRDA Strong Buy
- MCR
- Analyst Count
- TRDA 3
- MCR 0
- Target Price
- TRDA $25.67
- MCR N/A
- AVG Volume (30 Days)
- TRDA 126.5K
- MCR 66.7K
- Earning Date
- TRDA 08-12-2025
- MCR 01-01-0001
- Dividend Yield
- TRDA N/A
- MCR 8.52%
- EPS Growth
- TRDA N/A
- MCR N/A
- EPS
- TRDA 0.61
- MCR 0.38
- Revenue
- TRDA $172,220,000.00
- MCR N/A
- Revenue This Year
- TRDA N/A
- MCR N/A
- Revenue Next Year
- TRDA N/A
- MCR N/A
- P/E Ratio
- TRDA $11.70
- MCR $16.61
- Revenue Growth
- TRDA 5.74
- MCR N/A
- 52 Week Low
- TRDA $6.94
- MCR $5.63
- 52 Week High
- TRDA $21.79
- MCR $6.70
- Technical
- Relative Strength Index (RSI)
- TRDA 36.18
- MCR 47.66
- Support Level
- TRDA $6.94
- MCR $6.27
- Resistance Level
- TRDA $8.49
- MCR $6.35
- Average True Range (ATR)
- TRDA 0.42
- MCR 0.04
- MACD
- TRDA -0.07
- MCR -0.01
- Stochastic Oscillator
- TRDA 10.91
- MCR 13.64
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests the assets in Debt Instruments, Corporate Bonds, U.S. Government Securities, Foreign Government Securities, Securitized Instruments, Derivatives, Principal Risks, Debt Management Risk, Investment Selection Risk, Interest Rate Risk, Credit Risk, Foreign Risks, Emerging Markets Risk, Currency Risk, Leveraging Risk, Operational and Cybersecurity Risk, Active and Frequent Trading, and etc of different market countries.